A unique Australian trial currently being conducted by Neurotech International (ASX: NTI) is looking to make a breakthrough in the treatment of major paediatric neurological disorders. Speaking at a special seminar today, professor Russell Dale, co-principal investigator for Neurotech’s NTI164 clinical trial, said the studies are investigating the potential for the drug to provide the […]
The post Neurotech International progressing promising paediatric treatment appeared first on Small Caps.
Global Securities Lenders specializes in custom liquidity solutions for those seeking to leverage concentrated market positions quickly, conveniently, and confidentially. We provide flexible terms and low interest rates specifically designed with your goals in mind. GSL recently announced our goal of working in Australia to provide securities lending to companies and high net worth individuals.
Securities-based lending, or a stock loan, is the practice of using market investments such as stocks, ETF’s, warrants, bonds, or real estate investment trusts as collateral for a loan. If you own free-trading, non-restricted stock on a major world exchange that trades at a minimum volume of $30,000 USD daily, you can qualify for a non-recourse, collateralized stock loan from one of our valued lenders in record time! Get an instant quote to see if you qualify.
Original Article: Read More
Original Source: Small Caps
Categories: Biotech & Pharma, NTI